赛默飞世尔的Oncomine Dx Target Test获得FDA批准,作为伴随诊断识别符合最新靶向疗法的非小细胞肺癌患者
赛默飞世尔的Oncomine Dx Target Test获得FDA批准,作为伴随诊断识别符合最新靶向疗法的非小细胞肺癌患者
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.